Sage Therapeutics shares owned by T. Rowe Price Associates
Quarter-by-quarter ownership of Sage Therapeutics (SAGE) shares owned by T. Rowe Price Associates
from 13F filings
Historical chart of T. Rowe Price Associates investment in Sage Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Sage Therapeutics held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Sage Therapeutics by T. Rowe Price Associates
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $10M | 478k | 21.67 |
| 2023-09-30 | $12M | 582k | 20.58 |
| 2023-06-30 | $51M | 1.1M | 47.02 |
| 2023-03-31 | $80M | 1.9M | 41.96 |
| 2022-12-31 | $72M | 1.9M | 38.14 |
| 2022-03-31 | $71M | 2.2M | 33.10 |
| 2021-12-31 | $60M | 1.4M | 42.54 |
| 2021-09-30 | $62M | 1.4M | 44.31 |
| 2021-06-30 | $89M | 1.6M | 56.81 |
| 2021-03-31 | $180M | 2.4M | 74.85 |
| 2020-12-31 | $204M | 2.4M | 86.51 |
| 2020-09-30 | $156M | 2.6M | 61.12 |
| 2020-06-30 | $117M | 2.8M | 41.58 |
| 2020-03-31 | $85M | 3.0M | 28.72 |
| 2019-12-31 | $408M | 5.6M | 72.19 |
| 2019-09-30 | $1.0B | 7.5M | 140.29 |
| 2019-06-30 | $1.4B | 7.9M | 183.09 |
| 2019-03-31 | $1.3B | 8.3M | 159.05 |
| 2018-12-31 | $768M | 8.0M | 95.79 |
| 2018-09-30 | $1.1B | 7.8M | 141.25 |
| 2018-06-30 | $1.2B | 7.6M | 156.53 |
| 2018-03-31 | $1.2B | 7.2M | 161.07 |
| 2017-12-31 | $1.0B | 6.3M | 164.71 |
| 2017-06-30 | $282M | 3.5M | 79.64 |
| 2017-03-31 | $237M | 3.3M | 71.07 |
| 2016-12-31 | $131M | 2.6M | 51.06 |
| 2016-09-30 | $65M | 1.4M | 46.05 |
| 2016-06-30 | $14M | 471k | 30.13 |
| 2016-03-31 | $12M | 382k | 32.06 |
| 2015-12-31 | $22M | 382k | 58.30 |
| 2015-09-30 | $31M | 732k | 42.32 |
| 2015-03-31 | $4.5M | 90k | 50.23 |